Alvotech (ICE: ALVO)
Iceland
· Delayed Price · Currency is ISK
1,875.00
-5.00 (-0.27%)
At close: Jan 17, 2025
Alvotech Revenue
Alvotech had revenue of $102.99M USD in the quarter ending September 30, 2024, with 478.60% growth. This brings the company's revenue in the last twelve months to $393.92M, up 517.92% year-over-year. In the year 2023, Alvotech had annual revenue of $93.38M with 9.84% growth.
Revenue (ttm)
$393.92M
Revenue Growth
+517.92%
P/S Ratio
n/a
Revenue / Employee
$394.31K
Employees
999
Market Cap
563.99B ISK
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 93.38M | 8.37M | 9.84% |
Dec 31, 2022 | 85.02M | 45.33M | 114.23% |
Dec 31, 2021 | 39.68M | -29.77M | -42.86% |
Dec 31, 2020 | 69.45M | -13.23M | -16.00% |
Dec 31, 2019 | 82.68M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Marel | 250.20B |
Íslandsbanki | 62.96B |
Arion banki | 61.68B |
Sildarvinnslan Hf. | 43.52B |
Brim hf. | 58.07B |
Hagar | 177.12B |
Kvika banki | 15.14B |
Festi | 147.75B |
Alvotech News
- 4 weeks ago - Alvotech Added to Nasdaq Biotech Index Effective Monday December 23, 2024 - GlobeNewsWire
- 4 weeks ago - Alvotech Added to Nasdaq Biotech Index Effective Monday December 23, 2024 - GlobeNewsWire
- 2 months ago - Alvotech's Position In The Coming Biosimilar Gold Rush - Seeking Alpha
- 2 months ago - Alvotech (ALVO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Alvotech Attending Citi's Global Healthcare Conference on December 4, 2024, and Evercore's HealthCONx Conference on December 5, 2024 - GlobeNewsWire
- 2 months ago - European Medicines Agency Confirms Acceptance of Marketing Authorization Application for AVT05, a Proposed Biosimilar to Simponi® (golimumab) - GlobeNewsWire
- 3 months ago - Alvotech Meeting Investors and Presenting at the Jefferies 2024 London Healthcare Conference on November 19–20, 2024 - GlobeNewsWire
- 3 months ago - Alvotech Meeting Investors and Presenting at the Jefferies 2024 London Healthcare Conference on November 19–20, 2024 - GlobeNewsWire